Results
143
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
143 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
GTMA.Y | US$2.00 | 0% | 257.1% | US$69.8m | n/a | PE16.9x | n/a | n/a | ||
MARP.S | US$3.99 | -1.0% | -6.5% | US$8.0m | n/a | PE13.3x | n/a | 9.1% | ||
SND | US$2.25 | -1.7% | 12.5% | US$96.6m | US$3.00 | PS0.3x | E168.2% | 4.4% | ||
CHKR | US$0.51 | -0.8% | -26.1% | US$23.8m | n/a | PE5.4x | n/a | 23.8% | ||
SLNG | US$6.98 | -9.8% | 63.1% | US$129.7m | US$10.50 | PE33.1x | E-5.9% | n/a | ||
NXXT | US$3.05 | -3.2% | -29.1% | US$340.6m | n/a | PS12.8x | n/a | n/a | ||
AMPY | US$5.05 | -4.9% | -17.8% | US$201.7m | US$9.83 | PE3.3x | E4.2% | 0% | ||
NOV | US$15.11 | -2.8% | -12.3% | US$5.8b | US$18.87 | PE9.1x | E3.9% | 2.0% | ||
MVO | US$5.33 | -1.7% | -53.3% | US$61.3m | n/a | PE3.4x | n/a | 28.4% | ||
WKC New | US$30.73 | 12.4% | 18.3% | US$1.8b | US$30.60 | PE26.5x | E39.3% | 2.2% | ||
EXE | US$104.14 | -1.1% | 27.1% | US$24.1b | US$117.92 | PE94.7x | E64.4% | 2.2% | ||
SM | US$34.35 | -10.8% | -17.1% | US$3.9b | US$52.67 | PE5.1x | E0.1% | 2.3% | ||
MUR | US$27.31 | -3.4% | -30.7% | US$4.0b | US$37.12 | PE9.7x | E12.6% | 4.8% | ||
AESI | US$20.63 | -5.7% | 12.6% | US$2.5b | US$25.50 | PE30.9x | E53.9% | 4.7% | ||
EE | US$28.35 | -2.6% | 105.9% | US$3.1b | US$31.40 | PE26.8x | E16.4% | 0.8% | ||
INDO | US$2.79 | 0.7% | 16.3% | US$28.9m | n/a | PS9.2x | n/a | n/a | ||
RRC | US$38.48 | -0.5% | 23.5% | US$9.3b | US$39.93 | PE19.5x | E16.4% | 0.8% | ||
HES | US$148.11 | 1.1% | -0.7% | US$45.5b | US$169.71 | PE16.4x | E11.2% | 1.4% | ||
GRNT | US$6.13 | -1.4% | -0.3% | US$801.5m | US$7.56 | PE16.8x | E38.8% | 7.2% | ||
PBF | US$23.20 | 0% | -51.0% | US$2.7b | US$26.31 | PS0.08x | E65.6% | 4.7% | ||
ESOA | US$9.82 | 0.8% | 29.0% | US$164.6m | US$20.00 | PE6.9x | n/a | 0.3% | ||
TTI | US$4.20 | -5.2% | 10.8% | US$553.6m | US$6.30 | PE77.4x | E56.3% | n/a | ||
CHRD | US$111.67 | 0.7% | -30.1% | US$6.8b | US$166.81 | PE7.3x | E-2.4% | 9.1% | ||
ENSV | US$0.04 | 22.1% | -80.0% | US$2.4m | n/a | PS0.1x | n/a | n/a |